Dr. Reddy’s completes Mayne Pharma’s U.S. portfolio buyout
H.Q. Team April 7, 2023: Dr. Reddy’s Laboratories, an Indian maker of generics and active pharmaceutical ingredients, has completed the acquisition of Mayne.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
H.Q. Team April 7, 2023: Dr. Reddy’s Laboratories, an Indian maker of generics and active pharmaceutical ingredients, has completed the acquisition of Mayne.
HQ Team April 5, 2023: Arbutus Biopharma Corporation and Genevant Sciences filed a lawsuit in a US court seeking compensation for Pfizer and BioNTech’s unlicensed use.
HQ Team April 5, 2023: Johnson and Johnson, a US multinational making pharmaceuticals and medical devices, has offered to pay $8.9 billion to.
HQ Team April 4, 2023: About one in six people worldwide suffer from infertility, a disease that disables the male or female reproductive.
HQ Team April 3, 2023: BioNTech SE and Duality Biologics (Suzhou) have signed a $1.5 billion deal to develop and commercialise two cancer.
HQ Team April 3, 2023: Totto Learning, an India-based online parenting company, unveiled its artificial intelligence application, Cuddle, to support pregnant women and.
The CDC laboratory testing identified the presence of the outbreak strain in opened EzriCare bottles with different lot numbers collected from two states.
Obesity is a global concern and the WHO maybe forced add obesity drugs to its essential medicine list
A man in India is the world's first documented case of a plant fungal infection.
Researchers from the University of Copenhagen in Denmark have found asymptomatic people with undetected obstructive coronary atherosclerosis increase their risk for a heart.